Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate for Low Bone Mineral Density in Crohn's Disease
NCT01215890Phase 4Completed
- Sponsor
- University of Alberta
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in low bone mineral density, sponsored by University of Alberta. Status: completed.
02
Drugs
risedronate
03
Conditions
low bone mineral density
Beyond the preview
Go deeper on NCT01215890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215890.